Biology and Chemistry Program
Program Overview
Biology and Chemistry are two interdependent fields that play a crucial role in our understanding and treatment of human health. From developing new drugs to diagnosing diseases, chemistry has been instrumental in advancing the field of medicine. Chemists and medical professionals work together to explore the chemical basis of diseases, understand the molecular mechanisms of drugs, and develop new therapies and treatments. They use a range of tools and techniques, from imaging and spectroscopy to computational modeling and synthetic chemistry, to uncover the underlying chemical processes in the human body.
Biology and Chemistry majors have a diverse range of career opportunities available to them, including positions in academia, pharmaceuticals, medical practice, public and private healthcare, and more.
Eureka Alumni from this program have received admission offers to the University of Chicago, Duke University, and Emory University, and other top US universities.
Alumni from this program have gone off to pursue majors in Financial Economics, Computer Science, Political Science, and Applied Mathematics.
The research experience and skills students receive at the Eureka Program have helped students get accepted to programs such as the MIT - LaunchX Entrepreneurship Summer Program, Stanford Cardiothoracic Surgery Skills Summer Institute (CSSSI), and other top summer programs.
Many students from this program are also very engaged in their communities, sharing in volunteering activities and starting non-profit organizations to help the community. During COVID-19, a Eureka student founded Mask Connections, an initiative to recycle disposable masks. Many alumni from this program have received top awards like Regeneron Science Talent Scholarship, U.S. Presidential Scholars Awards, and many others.
The below sections will provide more insight into the students that have attended this program and share their experiences and successes.
Research Topic Samples
Understanding and Treating B-Cell Precursor Acute Lymphoblastic Leukemia
B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) is a rapidly progressing subtype of leukemia that affects b-type lymphocytes and can be fatal if left untreated. Common treatments include radiation therapy, bone marrow transplant, immunotherapy, targeted drug therapies, and chemotherapy. However, relapsed BCP-ALL can be resistant to chemotherapy due to mutations in the NT5C2 gene, which is essential to cellular purine metabolism and found in the nervous system. New screening procedures are necessary to identify these rare mutations and improve treatment options for patients. A Eureka student conducted a study on this illness through the Biology and Chemistry Program.
College Admission Results
Attended Eureka
2021 Summer
High School Name
Scarsdale High School
Admission Offer Received
• Amherst College
• University of California - Los Angeles (UCLA)
Eureka Research Title
Resistance Modifying Agents And Their Uses To Combat Multidrug-Resistant Bacterial Infections
Attended Eureka
2020
High School Name
International Department Of Beijing National Day School
Admission Offer Received
• University of Chicago
Eureka Research Title
Medications For Treating Covid19 Induced Cytokine Storm
Attended Eureka
2020
High School Name
Middlesex School
Admission Offer Received
• University of Chicago
Eureka Research Title
Case Study On Open Angle Glaucoma
Attended Eureka
2020 Summer
High School Name
Middlesex School
Admission Offer Received
• John Hopkins University (JHU)
• Northwestern University
• Columbia University
• New York University (NYU)
Eureka Research Title
Are Genetic Engineering And Agroecology Compatible In The Means Of Precision Breeding Rice From Wild Relative Genes Against Bacterial Blight?